Home Tools
Log in
Cart

Search Result

Search Results for " gw2016 "

4

Compounds

Cat No. Product Name Synonyms Targets
T72577 Lapatinib tosylate GW2016 tosylate,GW572016 tosylate,GW572016 tosylate ; GW2016 tosylate
Lapatinib tosylate (GW572016), a robust and orally administered inhibitor specifically targeting the tyrosine kinase domains of ErbB-2 and EGFR, exhibits inhibitory concentration 50 (IC50) values of 10.2 nM and 9.8 nM ag...
T0078 Lapatinib GSK572016,GW572016 EGFR , Ferroptosis , Autophagy
Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity. Lapatinib has antitumor activity and can be used to treat advanced or metastatic breast cancer with HER2 overexpression.
T0078L Lapatinib ditosylate monohydrate Lapatinib ditosylate monohydrate,Lapatinib ditoluenesulfonate monohydrate,Lapatinib tosilate hydrate,Lapatinib tosilate,Tykerb,Tyverb EGFR , Ferroptosis , Autophagy
Lapatinib ditosylate (Lapatinib tosilate) monohydrate is a tyrosine kinase receptor inhibitor used in the therapy of advanced breast cancer and other solid tumors. Lapatinib ditosylate monohydrate therapy is associated w...
T6235 Lapatinib Ditosylate Lapatinib (GW-572016) Ditosylate,GW-572016 ditosylate,Tykerb ditosylate EGFR , Ferroptosis , Autophagy
Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).
TargetMol